The Lymphoma-Associated Macrophage to Hodgkin-Reed-Sternberg Cell Ratio Is a Poor Prognostic Factor in Classic Hodgkin Lymphoma Patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Lymphoma-Associated Macrophage to Hodgkin-Reed-Sternberg Cell Ratio Is a Poor Prognostic Factor in Classic Hodgkin Lymphoma Patients

Published:2019-10 Issue:10 Volume:19 Page:e573-e580
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Procházka Vít,Papajík Tomáš,Dýšková Tereza,Dihel Martin,Brychtová Světlana,Prouzová Zuzana,Kriegová Eva,Lukášová Marie,Hanáčková Veronika

Funder

Takeda Pharmaceuticals

International AG Investigator Initiated Sponsored Research

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference25 articles.

1. Cancer Incidence 2010 in the Czech Republic,2010

2. Treatment of Hodgkin lymphoma: a 50-year perspective;Canellos;J Clin Oncol,2014

3. Pharmacotherapy of Hodgkin lymphoma: standard approaches and future perspectives;Eichenauer;Expert Opin Pharmacother,2014

4. Reduced relative dose intensity of primary chemotherapy does not influence prognosis of patients with Hodgkin lymphoma;Raida;Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub,2014

5. ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Eichenauer;Ann Oncol,2018

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Macrophage-Based Therapeutic Strategies in Hematologic Malignancies;Cancers;2023-07-22

2. Prognostic significance of CD163- and CD68-expressing macrophages in nodular sclerosis Hodgkin lymphoma;Oncohematology;2022-01-29

3. Trabectedin overcomes doxorubicin-resistance, counteracts tumor-immunosuppressive reprogramming of monocytes and decreases xenograft growth in Hodgkin lymphoma;Cancer Letters;2021-03

4. BV-DHAP as salvage treatment for high risk adolescent Hodgkin lymphoma;Klinische Pädiatrie;2020-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3